SCHEMBL8048237

SCHEMBL8048237

CN1CCN(C(=O)Oc2ccc(CC(N)C(=O)OC(C)(C)C)cc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ITGB1 P05556 1/20 0.48
▸ ITGA4 P13612 1/20 0.48
▸ ITGB7 P26010 1/20 0.48
▸ CACNA1B Q00975 4/20 0.43
▸ RAB9A P51151 3/20 0.41
▸ MAPT P10636 2/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ KMT2A Q03164 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.38
▸ GPR119 Q8TDV5 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ CHRM1 P11229 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2058594 1.00 ITGB1 (0.48) ITGB1ITGA4ITGB7CACNA1BRAB9A
SCHEMBL4618111 0.91 SMN1; SMN2 (0.52) ITGB1ITGA4ITGB7CACNA1BRAB9A
SCHEMBL13043085 0.88 RAB9A (0.39) ITGB1ITGA4ITGB7CACNA1BRAB9A
SCHEMBL2058808 0.85 ITGB1 (0.48) ITGB1ITGA4ITGB7RAB9AMAPT
SCHEMBL2857963 0.84 ITGB1 (0.57) ITGB1ITGA4ITGB7MAPTALDH1A1
SCHEMBL8060168 0.84 ITGB1 (0.57) ITGB1ITGA4ITGB7MAPTALDH1A1
SCHEMBL2059100 0.78 P2RX7 (0.59) ITGB1ITGA4ITGB7CACNA1B
SCHEMBL10535089 0.78 MAPT (0.55) MAPTSMN1; SMN2HTTALDH1A1POLB
SCHEMBL17822347 0.77 ALDH1A1 (0.55) ITGB1ITGA4ITGB7RAB9AMAPT
SCHEMBL17822346 0.77 ALDH1A1 (0.55) ITGB1ITGA4ITGB7RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000051-A1 CARBAMYLOXY COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-17 — — EP claimed
WO-1999006390-A1 CARBAMYLOXY COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 — — WO claimed
Send feedback